Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
University of Chicago
Eli Lilly and Company
Aduro Biotech, Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Fox Chase Cancer Center